Click image to view original image
PharmaLegacyCarbon tetrachloride (CCl4)-induced hepatic fibrosis and cirrhosis in rodents is a well-established and widely accepted experimental model for the study of liver fibrosis and cirrhosis. In many aspects it mirrors the pattern of human disease associated with toxic damage. For example, the α-SMA expression, Stellate cell activation and key matrix components including collagen-1, MMPs and their inhibitors TIMPs have been indicated in the pathogenesis of this model. CCl4 induction elicits a reproducible and predictable fibrotic response in liver, making it a valuable basis for preclinical pharmacology studies of anti-fibrotic and anti-cirrhotic therapeutics and the pathophysiology study of liver fibrosis-cirrhosis-HCC changesis focused on Respiratory Disease Model the quality of, Respiratory Disease Model the basic, AutoimmuneDiseasesModel s brand, Quality guaranteed Respiratory Disease Model and other projects. even though in the rapid development of the project ,PharmaLegacy always stressed the balance between external opportunities and internal management, attaches great importance to the core competitiveness of enterprises to cultivate and shape. Our company take the value of customer service as the core competitiveness of enterprises, adhering to the honesty and integrity , the pursuit of excellence, respect individual for the corporate spirit, and strive to provide customers with integrity and reliable Respiratory Disease Model.
PharmaLegacyadheres to advance with the times and advocates to the service-oriented,faith-based, people-oriented management idea. With a belief of customer first to forge ahead , company insists on providing our clients with satisfying and best service ofRheumatoid arthritis Model,Humanized micex2a3868en,
